These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24908534)

  • 1. Mucopolysaccharidosis type II with inguinal hernia.
    Rayamajhi A; Pokharel PJ; Chapagain R; Rayamajhi AK
    J Nepal Health Res Counc; 2013 Sep; 11(25):293-5. PubMed ID: 24908534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).
    Martin R; Beck M; Eng C; Giugliani R; Harmatz P; Muñoz V; Muenzer J
    Pediatrics; 2008 Feb; 121(2):e377-86. PubMed ID: 18245410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS).
    Alcalde-Martín C; Muro-Tudelilla JM; Cancho-Candela R; Gutiérrez-Solana LG; Pintos-Morell G; Martí-Herrero M; Munguira-Aguado P; Galán-Gómez E
    Eur J Med Genet; 2010; 53(6):371-7. PubMed ID: 20709629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucopolysaccharidosis type II in females: case report and review of literature.
    Tuschl K; Gal A; Paschke E; Kircher S; Bodamer OA
    Pediatr Neurol; 2005 Apr; 32(4):270-2. PubMed ID: 15797184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, biochemical and molecular characteristics of Filipino patients with mucopolysaccharidosis type II - Hunter syndrome.
    Chiong MA; Canson DM; Abacan MA; Baluyot MM; Cordero CP; Silao CL
    Orphanet J Rare Dis; 2017 Jan; 12(1):7. PubMed ID: 28077157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hunter syndrome with late age of presentation: clinical description of a case and review of the literature.
    Gupta A; Uttarilli A; Dalal A; Girisha KM
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25976201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucopolysaccharidosis type II, Hunter's syndrome.
    Tylki-Szymańska A
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():107-13. PubMed ID: 25345092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful use of spinal anesthesia for inguinal hernia repair in a child with Hunter syndrome with difficult airway.
    Kumar KR; Kumar H; Baidya DK; Arora MK
    J Clin Anesth; 2016 May; 30():99-100. PubMed ID: 26604014
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term enzyme replacement therapy in a severe case of mucopolysaccharidosis type II (Hunter syndrome).
    Papadia F; Lozupone MS; Gaeta A; Capodiferro D; Lacalendola G
    Eur Rev Med Pharmacol Sci; 2011 Mar; 15(3):253-8. PubMed ID: 21528770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene.
    Christianto A; Watanabe H; Nakajima T; Inazu T
    Clin Chim Acta; 2013 Aug; 423():66-8. PubMed ID: 23726270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inguinal hernia in the Hurler-Hunter syndrome.
    Coran AG; Eraklis AJ
    Surgery; 1967 Feb; 61(2):302-4. PubMed ID: 4959673
    [No Abstract]   [Full Text] [Related]  

  • 13. The management of children with Hunter syndrome - a case study.
    Little C; Gould R; Hendriksz C
    Br J Nurs; 2009 Mar 12-25; 18(5):321-2. PubMed ID: 19273994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A for the treatment of equinus deformity in patients with mucopolysaccharidosis type II.
    Nava E; Weber P; Gautschi M; Nuoffer JM; Grunt S
    J Child Neurol; 2012 Dec; 27(12):1611-5. PubMed ID: 22433425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation and diagnosis of mucopolysaccharidosis type 2 (Hunter syndrome).
    Patil R; Wasekar N; Jadhav SG; Zore R; Sangoi P; Vishwanathan D
    J Assoc Physicians India; 2013 Aug; 61(8):574-6. PubMed ID: 24818348
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucopolysaccharidosis type II: skeletal-muscle system involvement.
    Morini SR; Steiner CE; Gerson LB
    J Pediatr Orthop B; 2010 Jul; 19(4):313-7. PubMed ID: 20354449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial report from the Hunter Outcome Survey.
    Wraith JE; Beck M; Giugliani R; Clarke J; Martin R; Muenzer J;
    Genet Med; 2008 Jul; 10(7):508-16. PubMed ID: 18580692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995-2012.
    Lin HY; Chuang CK; Huang YH; Tu RY; Lin FJ; Lin SJ; Chiu PC; Niu DM; Tsai FJ; Hwu WL; Chien YH; Lin JL; Chou YY; Tsai WH; Chang TM; Lin SP
    Orphanet J Rare Dis; 2016 Jun; 11(1):85. PubMed ID: 27349225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical spine MRI findings in patients with Mucopolysaccharidosis type II.
    Żuber Z; Jurecka A; Jurkiewicz E; Kieć-Wilk B; Tylki-Szymańska A
    Pediatr Neurosurg; 2015; 50(1):26-30. PubMed ID: 25721852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidisciplinary management of Hunter syndrome.
    Muenzer J; Beck M; Eng CM; Escolar ML; Giugliani R; Guffon NH; Harmatz P; Kamin W; Kampmann C; Koseoglu ST; Link B; Martin RA; Molter DW; Muñoz Rojas MV; Ogilvie JW; Parini R; Ramaswami U; Scarpa M; Schwartz IV; Wood RE; Wraith E
    Pediatrics; 2009 Dec; 124(6):e1228-39. PubMed ID: 19901005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.